US government funds psychedelic therapy research for the first time in 50 years

Fifty years after being classified as a Schedule I drug in the US, psychedelic therapy has officially received federal funding from the government in what researchers see as a huge shift in the medical and public perception of the benefits of psychedelics.

Using psychedelics to help treat…

Click here to view the original article.